189 related articles for article (PubMed ID: 9454742)
21. Activated protein C resistance and thrombosis: molecular mechanisms of hypercoagulable state due to FVR506Q mutation.
Dahlbäck B
Semin Thromb Hemost; 1999; 25(3):273-89. PubMed ID: 10443959
[TBL] [Abstract][Full Text] [Related]
22. A factor V genetic component differing from factor V R506Q contributes to the activated protein C resistance phenotype.
Bernardi F; Faioni EM; Castoldi E; Lunghi B; Castaman G; Sacchi E; Mannucci PM
Blood; 1997 Aug; 90(4):1552-7. PubMed ID: 9269773
[TBL] [Abstract][Full Text] [Related]
23. Polymorphisms at activated protein C cleavage sites of factor V: Are they important in the absence of factor V Leiden?
Kheradmand E; Haghjooy-Javanmard S; Dehghani L; Saadatnia M
Iran J Neurol; 2017 Jan; 16(1):30-33. PubMed ID: 28717431
[No Abstract] [Full Text] [Related]
24. Functional characterization of factor V-Ile359Thr: a novel mutation associated with thrombosis.
Steen M; Norstrøm EA; Tholander AL; Bolton-Maggs PH; Mumford A; McVey JH; Tuddenham EG; Dahlbäck B
Blood; 2004 May; 103(9):3381-7. PubMed ID: 14695241
[TBL] [Abstract][Full Text] [Related]
25. Pro- and anticoagulant properties of factor V in pathogenesis of thrombosis and bleeding disorders.
Dahlbäck B
Int J Lab Hematol; 2016 May; 38 Suppl 1():4-11. PubMed ID: 27161771
[TBL] [Abstract][Full Text] [Related]
26. The discovery of activated protein C resistance.
Dahlbäck B
J Thromb Haemost; 2003 Jan; 1(1):3-9. PubMed ID: 12871530
[TBL] [Abstract][Full Text] [Related]
27. Venous thrombosis in a replanted finger with underlying factor V Leiden mutation.
Kenner L; Schwarzl F; Moshammer H; Haas F; Hoefler G; Pierer G
Br J Plast Surg; 1998 Jan; 51(1):57-8. PubMed ID: 9577320
[TBL] [Abstract][Full Text] [Related]
28. Impaired APC cofactor activity of factor V plays a major role in the APC resistance associated with the factor V Leiden (R506Q) and R2 (H1299R) mutations.
Castoldi E; Brugge JM; Nicolaes GA; Girelli D; Tans G; Rosing J
Blood; 2004 Jun; 103(11):4173-9. PubMed ID: 14976057
[TBL] [Abstract][Full Text] [Related]
29. [Activated protein C resistance: role in venous and arterial thrombosis].
Emmerich J; Alhenc-Gelas M; Aiach M; Fiessinger JN
Arch Mal Coeur Vaiss; 1996 Jun; 89(6):741-5. PubMed ID: 8760661
[TBL] [Abstract][Full Text] [Related]
30. Modification of the ProC Global assay using dilution of patient plasma in factor V-depleted plasma as a screening assay for factor V Leiden mutation.
Quincampoix JC; Legarff M; Rittling C; Andiva S; Toulon P
Blood Coagul Fibrinolysis; 2001 Oct; 12(7):569-76. PubMed ID: 11685046
[TBL] [Abstract][Full Text] [Related]
31. Inherited resistance to activated protein C, a major cause of venous thrombosis, is due to a mutation in the factor V gene.
Dahlbäck B
Haemostasis; 1994; 24(2):139-51. PubMed ID: 7959362
[TBL] [Abstract][Full Text] [Related]
32. Activated protein C resistance in ischemic stroke not due to factor V arginine506-->glutamine mutation.
Fisher M; Fernandez JA; Ameriso SF; Xie D; Gruber A; Paganini-Hill A; Griffin JH
Stroke; 1996 Jul; 27(7):1163-6. PubMed ID: 8685921
[TBL] [Abstract][Full Text] [Related]
33. Arterial and venous thrombosis in two Italian families with the factor V Arg506-->Gln mutation.
Montaruli B; Voorberg J; Tamponi G; Borchiellini A; Muleo G; Pannocchia A; van Mourik JA; Schinco P
Eur J Haematol; 1996 Jul; 57(1):96-100. PubMed ID: 8698138
[TBL] [Abstract][Full Text] [Related]
34. Resistance to activated protein C and a novel factor V gene mutation.
Voelkerding KV
Clin Lab Med; 1996 Mar; 16(1):169-86. PubMed ID: 8867589
[TBL] [Abstract][Full Text] [Related]
35. Low thrombosis rate seen in blood donors and their relatives with inherited deficiencies of antithrombin and protein C: correlation with type of defect, family history, and absence of the factor V Leiden mutation.
McColl M; Tait RC; Walker ID; Perry DJ; McCall F; Conkie JA
Blood Coagul Fibrinolysis; 1996 Oct; 7(7):689-94. PubMed ID: 8958391
[TBL] [Abstract][Full Text] [Related]
36. A novel mutation (g2172-->c) in the factor V gene in a Chinese family with hereditary activated protein C resistance.
Cai H; Hua B; Fan L; Wang Q; Wang S; Zhao Y
Thromb Res; 2010 Jun; 125(6):545-8. PubMed ID: 20304467
[TBL] [Abstract][Full Text] [Related]
37. Factor V gene mutation causing inherited resistance to activated protein C as a basis for venous thromboembolism.
Dahlbäck B
J Intern Med; 1995 Mar; 237(3):221-7. PubMed ID: 7891043
[TBL] [Abstract][Full Text] [Related]
38. Cleavage at both Arg306 and Arg506 is required and sufficient for timely and efficient inactivation of factor Va by activated protein C.
Barhoover MA; Kalafatis M
Blood Coagul Fibrinolysis; 2011 Jun; 22(4):317-24. PubMed ID: 21467919
[TBL] [Abstract][Full Text] [Related]
39. Novel APC-cleavage sites in FVa provide insights into mechanisms of action of APC and its cofactor protein S.
Tran S; Dahlbäck B
J Thromb Haemost; 2010 Jan; 8(1):129-36. PubMed ID: 19874463
[TBL] [Abstract][Full Text] [Related]
40. The VITA project: phenotypic resistance to activated protein C and FV Leiden mutation in the general population. Vicenza Thrombophilia and Atherosclerosis.
Tosetto A; Missiaglia E; Gatto E; Rodeghiero F
Thromb Haemost; 1997 Aug; 78(2):859-63. PubMed ID: 9268185
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
